Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.

ABSTRACT:

SUBMITTER: Debie Y 

PROVIDER: S-EPMC8714294 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature